Abstract

Ergotism is a complication of the acute intoxication or chronic abuse of ergot derivatives. It may be manifested by a vasomotor syndrome with peripheral vascular disease frequently involving extremities. We report three patients infected with human immunodeficiency virus (HIV), in antiretroviral treatment (ART) that included a protease inhibitor as ritonavir, and had received self-medicated ergotamine. They developed symptoms of peripheral vascular disease and the physical examination showed no arterial pulses in the affected vessels. Arterial Doppler confirmed signs of diffuse arterial spasm in all of them. An arteriography was performed to the second patient and it showed obliteration of the distal sector of the ulnar and radial arteries. Ergotism secondary to ergotamine-ritonavir association was diagnosed. Patients were treated discontinuing the administration of involved drugs, arterial vasodilators and prophylactic anticoagulation, with marked improvement of symptoms.

Highlights

  • Ergotism is a complication of the acute intoxication or chronic abuse of ergot derivatives

  • We report three patients infected with human immunodeficiency virus (HIV), in antiretroviral treatment (ART) that included a protease inhibitor as ritonavir, and had received self-medicated ergotamine

  • Los casos clínicos presentados sugieren que el ritonavir puede asociarse con el desarrollo de ergotismo severo en pacientes tratados con derivados ergotamínicos

Read more

Summary

Introduction

Ergotism is a complication of the acute intoxication or chronic abuse of ergot derivatives. La vasculopatía ergotamínica forma parte del grupo de los acrosindromes vasculares, se presenta en pacientes que ingieren ergotamina independientemente de la dosis, en asociación o no con otros fármacos que inhiben su metabolismo hepático[1,2].

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.